Subgroup analysis of ARCADIA in cryptogenic stroke: in 937 randomised patients, infarcts in 2 or 3 territories were associated with higher recurrent stroke risk (HR 2.4 and 3.7) vs one, with no modification of apixaban vs aspirin effect.
Secondary analysisn = 3,464
Gologorsky et al. Multiterritory Brain Infarcts, Anticoagulation, and Recurrence After Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA Trial